These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13724915)

  • 1. A new high potency antidiabetic sulfonylurea [N-(1-hexahydro-1-azepinyl)-N'-p-tolyl-sulfonylurea].
    DULIN WE; OSTER HL; McMAHON FG
    Proc Soc Exp Biol Med; 1961 Jun; 107():245-8. PubMed ID: 13724915
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoglycemic potency in man of a new sulfonylurea derivative (chlorpropamide).
    WEST KM; McCAMPBELL SR
    Proc Soc Exp Biol Med; 1958; 98(4):724-5. PubMed ID: 13591321
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of long-term use of antidiabetic sulfonylureas on thyroid weight and arteriosclerosis.
    NIKKILA EA; TEIR H
    Ann Med Exp Biol Fenn; 1960; 38():182-5. PubMed ID: 14427203
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and hazards of an experimental hypoglycemic sulfonylurea compound: metahexamide].
    VERNET A; RILLIET B
    Praxis; 1960 Jun; 49():620-3. PubMed ID: 13841881
    [No Abstract]   [Full Text] [Related]  

  • 5. Disulfiramlike actions produced by hypoglycemic sulfonylurea compounds.
    TRUITT EB; DURITZ G; MORGAN AM; PROUTY RW
    Q J Stud Alcohol; 1962 Jun; 23():197-207. PubMed ID: 13922688
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the problem of the protective effect of sulfonylurea derivatives on the liver].
    KNICK B; RUCKES J
    Verh Dtsch Ges Inn Med; 1959; 65():709-12. PubMed ID: 14410106
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of sulfonylurea on proliferating connective tissue in the liver].
    PETZOLD H; STOEHR K
    Verh Dtsch Ges Inn Med; 1959; 65():455-9. PubMed ID: 14432454
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of long-term sulfonylurea treatment on the haematopoietic system of diabetic patients.
    JAKOBSON T
    Ann Med Intern Fenn; 1961; 50():83-93. PubMed ID: 13789246
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative pharmacology of the sulfonylureas.
    RADDING RS; KERN LR; OWENS JC
    Metabolism; 1962 Apr; 11():411-5. PubMed ID: 14489728
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the significant role of the liver in sulfonylurea hypoglycemia.
    FRAWLEY TF; SHELLEY TF; RUNYAN JW; MARGULIES EJ; CINCOTTI JJ
    Ann N Y Acad Sci; 1959 Sep; 82():460-78. PubMed ID: 13824663
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism and relative hypoglycemic potencies of four sulfonylureas in man.
    WEST KM; JOHNSON PC
    Diabetes; 1960; 9():454-8. PubMed ID: 13784586
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of orally administered biguanide and sulfonylurea with reference to a test for latent diabetes mellitus].
    GUTSCHE H
    Arzneimittelforschung; 1961 Dec; 11():1127-30. PubMed ID: 13903204
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the sulphonylureas on fibrinolysis.
    FEARNLEY GR; CHAKRABARTI R; VINCENT CT
    Lancet; 1960 Sep; 2(7151):622-5. PubMed ID: 13698486
    [No Abstract]   [Full Text] [Related]  

  • 14. On the hypoglycemizing effect of metahexamide.
    GARATTINI S; JORI A; PALMA V; TESSARI L
    Experientia; 1959 Oct; 15():384-5. PubMed ID: 13826354
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the action of hypoglycemia-producing biguanide and sulfonylurea compounds on oxidative phosphorylation.
    FALCONE AB; MAO RL; SHRAGO E
    J Biol Chem; 1962 Mar; 237():904-9. PubMed ID: 13891416
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative effect of various hypoglycemic sulfonylurea compounds on thyroid function in the rat].
    ZIZINE L
    Ann Endocrinol (Paris); 1957; 18(4):673-5. PubMed ID: 13498450
    [No Abstract]   [Full Text] [Related]  

  • 17. Data on the combined action of insulin and hypoglycaemic sulphonylurea.
    TARDOS L; ERDELY I
    Acta Physiol Acad Sci Hung; 1961; 19():297-303. PubMed ID: 13775313
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition and activation of DPN-dependent zinc-containing enzymes by hypoglycemic sulfonylurea compounds].
    WALLENFELS K; SUMM HD
    Klin Wochenschr; 1957 Sep; 35(17):849-51. PubMed ID: 13515081
    [No Abstract]   [Full Text] [Related]  

  • 19. The current status of sulphonylureas in experimental and clinical diabetes.
    TYLER DB
    J Indian Med Assoc; 1960 Dec; 35():549-51. PubMed ID: 13778866
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid function in diabetic patients under long-term sulfonylurea treatment.
    NIKKILA EA; JAKOBSON T; JOKIPII SG; KARLSSON K
    Acta Endocrinol (Copenh); 1960 Apr; 33():623-9. PubMed ID: 14427195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.